Clearbridge partners Australia's Genome.One for personal health genomics programme

Clearbridge partners Australia's Genome.One for personal health genomics programme

By: 
Michelle Zhu
26/06/18, 06:17 pm

SINGAPORE (June 26): Clearbridge Health (CBH) is partnering Australia-based health information company Genome.One, a wholly-owned subsidiary of Garvan Institute of Medical Research, to offer its patients genomic testing and analysis with the latter’s Genome.One GoExplore personal health genomics programme.

The programme sequences and analyses individual DNA samples assess their risk of developing 52 hereditary conditions, including 31 cancers, 13 heart conditions, as well as several other conditions where monitoring or intervention can be of benefit.

The test will also determine patients’ likely response to over 220 different types of medication.

Under the partnership, Clearbridge clinicians will refer patients in Singapore and Hong Kong to the programme.

On the other hand, Genome.One’s genetic health professionals will provide pre- and post-testing support to these individuals via telehealth consultations, with interpreters and different language reports also available for non-English speaking patients.

In a Tuesday release, Clearbridge says its partnership with Genome.One is strongly in line with the group’s focus on the delivery of clinical-grade precision medicine by enabling healthcare professionals to gain better insights into management of hereditary conditions.

This is a ground-breaking test that will allow patients to understand their risk level in terms of hereditary conditions by analysing one’s unique genomic information and how the human body will react to a host of different medications, we are then able to provide customised and targeted preventive treatments for our patients,” comments Jeremy Yee, executive director and CEO of Clearbridge, on the Genome.One GoExplore programme.

“This partnership reinforces our commitment as a leading precision healthcare provider, to offer individualised and holistic solutions for future healthcare management,” he adds.

Shares in Clearbridge closed 1.4% higher at 36 cents on Tuesday.

Sasseur REIT rides on China's love for luxury goods

SINGAPORE (Apr 23): Following a site visit to Sasseur REIT’s outlet malls – Chongqing mall and Hefei mall – during their annual Spring sale, the REIT has attracted the attention of Phillip Capital. In an unrated report on Monday, analyst Natalie Ong says, “Sasseur’s outlet malls not only offer large discounts on branded goods targeted at the middle class, brand-conscious consumer, but also incorporate numerous activities and entertainment programmes to engage different age group.” According to Ong, luxury retail demand is expected to grow in China. Globally, Chinese consumers....
Read More >>

Don't demonise China but neither be its vassal state: Ho Kwon Ping

SINGAPORE (Apr 23): The current United States and China trade tensions, businessman Ho Kwon Ping thinks, is not about a trade war but about a paradigm shift towards China becoming a major global player who does not want to play by Western rules. Ho says: “The current US-China tensions are not only not about the trade war, it is not even about geopolitical or geo-economic rivalry. It is about an entire paradigm shift in civilisational relationships which has not happened for the last 200 to 300 years ever since the ascendancy of Western civilisation to become the dominant civilisation in t....
Read More >>

UOB KayHian remains positive as SPH turns to student accommodation to arrest flagging media business

SINGAPORE (Apr 23): Despite continued weakness in its core media business, UOB Kay Hian is staying positive on Singapore Press Holdings (SPH) on the back of its foray into the student accommodation segment. SPH last week announced it has acquired a portfolio of three purpose-built student accommodation (PBSA) assets in the UK for £134 million ($237 million). See: SPH expands UK student dorm portfolio with $237 mil acquisition The assets span three cities in the UK – Southampton, Sheffield and Leads – and has a total capacity of 1,243 beds, bringing SPH’s total portfolio to over....
Read More >>